NLRC5 and breast carcinoma: To address these critical gaps, the present study investigates the potential inhibitory effect of IFN-γ on miR-4319, its subsequent impact on NLRC5 expression, and the specific regulation of classical MHC class I subtypes in MHC class I – deficient SKBR3 breast cancer cells.